The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief?

DSpace/Manakin Repository

. . . . . .

Title:	The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief?
Author:	Kisloff, Michelle A.
Citation:	The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief? (1995 Third Year Paper)
Full Text & Related Files:	mkisloff.pdf (210.2Kb; PDF) mkisloff.rtf (98.23Kb; RTF file) mkisloff.html (65.54Kb; HTML)
Abstract:	Tylenol. Advil. Monistat 7. Imodium AD. These are some of the most commonly used, widely available, and successful drugs in the United States. All of them began as drugs only available by a prescription. All of them made a successful prescription-only to over-the-counter (Rx-to-OTC) switch through the switch" mechanisms of the Food and Drug Administration (FDA). Due to the amount of money that pharmaceutical companies can make with an Rx-to-OTC switch, the FDA has received dozens of switch requests in the last few years, and it expects to receive many more in the near future.
Terms of Use:	This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page:	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846781